Literature DB >> 23250749

Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease.

Jiu-Qiang Wang1, Qian Chen, Xianhua Wang, Qiao-Chu Wang, Yun Wang, He-Ping Cheng, Caixia Guo, Qinmiao Sun, Quan Chen, Tie-Shan Tang.   

Abstract

Huntington disease (HD) is an inherited, fatal neurodegenerative disorder characterized by the progressive loss of striatal medium spiny neurons. Indications of oxidative stress are apparent in brain tissues from both HD patients and HD mouse models; however, the origin of this oxidant stress remains a mystery. Here, we used a yeast artificial chromosome transgenic mouse model of HD (YAC128) to investigate the potential connections between dysregulation of cytosolic Ca(2+) signaling and mitochondrial oxidative damage in HD cells. We found that YAC128 mouse embryonic fibroblasts exhibit a strikingly higher level of mitochondrial matrix Ca(2+) loading and elevated superoxide generation compared with WT cells, indicating that both mitochondrial Ca(2+) signaling and superoxide generation are dysregulated in HD cells. The excessive mitochondrial oxidant stress is critically dependent on mitochondrial Ca(2+) loading in HD cells, because blocking mitochondrial Ca(2+) uptake abolished elevated superoxide generation. Similar results were obtained using neurons from HD model mice and fibroblast cells from HD patients. More importantly, mitochondrial Ca(2+) loading in HD cells caused a 2-fold higher level of mitochondrial genomic DNA (mtDNA) damage due to the excessive oxidant generation. This study provides strong evidence to support a new causal link between dysregulated mitochondrial Ca(2+) signaling, elevated mitochondrial oxidant stress, and mtDNA damage in HD. Our results also indicate that reducing mitochondrial Ca(2+) uptake could be a therapeutic strategy for HD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23250749      PMCID: PMC3561531          DOI: 10.1074/jbc.M112.407726

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  The reversible Ca2+-induced permeabilization of rat liver mitochondria.

Authors:  I Al-Nasser; M Crompton
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

Review 2.  Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease.

Authors:  Grace E Stutzmann; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

3.  Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

Authors:  Y Sun; A Savanenin; P H Reddy; Y F Liu
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

4.  Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.

Authors:  Jacqueline Shehadeh; Herman B Fernandes; Melinda M Zeron Mullins; Rona K Graham; Blair R Leavitt; Michael R Hayden; Lynn A Raymond
Journal:  Neurobiol Dis       Date:  2005-09-13       Impact factor: 5.996

5.  Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates.

Authors:  Hirokazu Fukui; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2007-03-13       Impact factor: 6.150

6.  In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease.

Authors:  Mary Y Heng; Peter J Detloff; Phillip L Wang; Joe Z Tsien; Roger L Albin
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

Review 7.  Huntingtin: alive and well and working in middle management.

Authors:  Marcy E MacDonald
Journal:  Sci STKE       Date:  2003-11-04

8.  Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease.

Authors:  Karina Acevedo-Torres; Lexsy Berríos; Nydia Rosario; Vanessa Dufault; Serguei Skatchkov; Misty J Eaton; Carlos A Torres-Ramos; Sylvette Ayala-Torres
Journal:  DNA Repair (Amst)       Date:  2008-11-20

9.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

10.  Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease.

Authors:  Dmitry Lim; Laura Fedrizzi; Marzia Tartari; Chiara Zuccato; Elena Cattaneo; Marisa Brini; Ernesto Carafoli
Journal:  J Biol Chem       Date:  2007-12-21       Impact factor: 5.157

View more
  43 in total

Review 1.  Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling.

Authors:  Nickolay Brustovetsky
Journal:  Mol Neurobiol       Date:  2015-05-05       Impact factor: 5.590

2.  Multiparametric optical analysis of mitochondrial redox signals during neuronal physiology and pathology in vivo.

Authors:  Michael O Breckwoldt; Franz M J Pfister; Peter M Bradley; Petar Marinković; Philip R Williams; Monika S Brill; Barbara Plomer; Anja Schmalz; Daret K St Clair; Ronald Naumann; Oliver Griesbeck; Markus Schwarzländer; Leanne Godinho; Florence M Bareyre; Tobias P Dick; Martin Kerschensteiner; Thomas Misgeld
Journal:  Nat Med       Date:  2014-04-20       Impact factor: 53.440

Review 3.  DNA damage response and repair pathway modulation by non-histone protein methylation: implications in neurodegeneration.

Authors:  Madhusoodanan Urulangodi; Abhishek Mohanty
Journal:  J Cell Commun Signal       Date:  2019-11-20       Impact factor: 5.782

4.  Setting the Stage: Genes Controlling Mechanosensation and Ca2+ Signaling in Escherichia coli.

Authors:  R Gary Sawers
Journal:  J Bacteriol       Date:  2021-01-11       Impact factor: 3.490

5.  Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease.

Authors:  Jessica J Pellman; James Hamilton; Tatiana Brustovetsky; Nickolay Brustovetsky
Journal:  J Neurochem       Date:  2015-06-04       Impact factor: 5.372

Review 6.  Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.

Authors:  Chaitanya R Joshi; Vinod Labhasetwar; Anuja Ghorpade
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-03       Impact factor: 4.147

7.  Genome-Wide Functional Screen for Calcium Transients in Escherichia coli Identifies Increased Membrane Potential Adaptation to Persistent DNA Damage.

Authors:  Rose Luder; Giancarlo N Bruni; Joel M Kralj
Journal:  J Bacteriol       Date:  2021-01-11       Impact factor: 3.490

8.  Mitochondrial flashes: new insights into mitochondrial ROS signalling and beyond.

Authors:  Tingting Hou; Xianhua Wang; Qi Ma; Heping Cheng
Journal:  J Physiol       Date:  2014-07-18       Impact factor: 5.182

Review 9.  PGC-1α, mitochondrial dysfunction, and Huntington's disease.

Authors:  Ashu Johri; Abhishek Chandra; M Flint Beal
Journal:  Free Radic Biol Med       Date:  2013-04-19       Impact factor: 7.376

10.  Adult neural progenitor cells from Huntington's disease mouse brain exhibit increased proliferation and migration due to enhanced calcium and ROS signals.

Authors:  Wenjuan Xie; Jiu-Qiang Wang; Qiao-Chu Wang; Yun Wang; Sheng Yao; Tie-Shan Tang
Journal:  Cell Prolif       Date:  2015-08-13       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.